Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Studies on PIVKA-X

G Gaudernack, H Prydz

    Thrombosis Et Diathesis Haemorrhagica
    |November 15, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Vitamin K-induced modifications did not affect protein survival or incorporation rates of PIVKA-X and factor X in Macaca mulatta. PIVKA-X showed greater inhibition in Russell's viper venom assays compared to tissue thromboplastin assays.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Lectin Stimulation of Tissue Thromboplastin Activity in Human Monocytes in vitro.

    Thrombosis and haemostasis·2019
    Same author

    Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model.

    Gene therapy·2015
    Same author

    Polyelectrolyte multilayer capsules with quantum dots for biomedical applications.

    Colloids and surfaces. B, Biointerfaces·2011
    Same author

    The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily.

    Scandinavian journal of immunology·2011
    Same author

    Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif.

    Leukemia·2010
    Same author

    Formation of biocompatible nanocapsules with emulsion core and pegylated shell by polyelectrolyte multilayer adsorption.

    Langmuir : the ACS journal of surfaces and colloids·2010
    Same journal

    Clinical and genetic aspects of Glanzmann's thrombasthenia in Israel: report of 22 cases.

    Thrombosis et diathesis haemorrhagica·1975
    Same journal

    Evans blue: a specific inhibitor of factor VIII-induced platelet agglutination.

    Thrombosis et diathesis haemorrhagica·1975
    Same journal

    Study of aggregate formation in region of separated blood flow.

    Thrombosis et diathesis haemorrhagica·1975
    Same journal

    Potato inhibitors of intrinsic prothrombin activators.

    Thrombosis et diathesis haemorrhagica·1975
    Same journal

    Adverse effect of heparin in thrombin-antithrombin III interaction.

    Thrombosis et diathesis haemorrhagica·1975
    Same journal

    Calculation of predictive odds for possible carriers of heamophilia.

    Thrombosis et diathesis haemorrhagica·1975
    See all related articles

    Area of Science:

    • Biochemistry
    • Hematology
    • Molecular Biology

    Background:

    • Protein synthesis and degradation are crucial in biological systems.
    • Vitamin K is essential for the post-translational modification of specific proteins, including coagulation factors.
    • PIVKA-X (Proteins Induced by Vitamin K Absence or Antagonism) are abnormal proteins produced in vitamin K deficiency.

    Purpose of the Study:

    • To investigate the incorporation and survival rates of PIVKA-X and factor X in Macaca mulatta.
    • To determine if vitamin K-induced modifications affect protein half-lives.
    • To compare the sensitivity of different assay systems to PIVKA-X inhibition.

    Main Methods:

    • Studied incorporation of 14C-glucosamine and 3H-leucine into PIVKA-X and factor X.

    Related Experiment Videos

  • Utilized monospecific precipitating antiserum for analysis in Macaca mulatta.
  • Assessed protein half-lives and inhibition sensitivity using Russell's viper venom/cephalin and tissue thromboplastin-based systems.

    • Main Results:

    • No significant difference was observed in the incorporation of 14C-glucosamine and 3H-leucine into PIVKA-X and factor X.
    • Similar half-lives were found for PIVKA-X (approximately 30-35 hours) and factor X (approximately 27-31 hours).
    • PIVKA-X demonstrated greater inhibition in a Russell's viper venom/cephalin test system compared to a tissue thromboplastin-based system.

    Conclusions:

    • Vitamin K-induced modifications do not alter the survival rate of PIVKA-X or factor X.
    • The half-lives of PIVKA-X and factor X are comparable, suggesting similar protein stability.
    • Assay methodology influences the detection of PIVKA-X inhibition, with Russell's viper venom/cephalin being more sensitive.